Please Wait
Applying Filters...
Menu
$ API Ref.Price (USD/KG) : 7Xls
Filters Filter
Cross PopUp
FILTER :

filter clear-filterReset all filters

01 3AFT PHARMS US

02 1FRESENIUS KABI USA

03 1HALEON US HOLDINGS

04 9MALLINCKRODT HOSP

05 12MALLINCKRODT INC

06 15ZEVRA THERAP

filter clear-filterReset all filters

filter clear-filterReset all filters

filter clear-filterReset all filters

filter clear-filterReset all filters

PharmaCompass

01

arrow
Antibody Engineering
Not Confirmed
arrow
Antibody Engineering
Not Confirmed

ACETAMINOPHEN

US Patent Number : 8741959

Drug Substance Claim :

Drug Product Claim : Y

Application Number : 204767

Patent Use Code :

Delist Requested :

Patent Use Description :

Patent Expiration Date : 2030-04-19

blank

02

arrow
Antibody Engineering
Not Confirmed
arrow
Antibody Engineering
Not Confirmed

ACETAMINOPHEN; IBUPROFEN

US Patent Number : 11918693

Drug Substance Claim :

Drug Product Claim : Y

Application Number : 211733

Patent Use Code :

Delist Requested :

Patent Use Description :

Patent Expiration Date : 2041-07-09

blank

03

arrow
Antibody Engineering
Not Confirmed
arrow
Antibody Engineering
Not Confirmed

ACETAMINOPHEN; OXYCODONE HYDROCHLORIDE

US Patent Number : 8668929

Drug Substance Claim :

Drug Product Claim :

Application Number : 204031

Patent Use Code : U-1499

Delist Requested :

Patent Use Description : MANAGEMENT OF ACUTE PA...

Patent Expiration Date : 2029-03-11

blank

04

arrow
Antibody Engineering
Not Confirmed
arrow
Antibody Engineering
Not Confirmed

ACETAMINOPHEN; OXYCODONE HYDROCHLORIDE

US Patent Number : 8377453

Drug Substance Claim :

Drug Product Claim : Y

Application Number : 204031

Patent Use Code : U-1499

Delist Requested :

Patent Use Description : MANAGEMENT OF ACUTE PA...

Patent Expiration Date : 2029-11-19

blank

05

arrow
Antibody Engineering
Not Confirmed
arrow
Antibody Engineering
Not Confirmed

ACETAMINOPHEN; OXYCODONE HYDROCHLORIDE

US Patent Number : 8741885

Drug Substance Claim :

Drug Product Claim : Y

Application Number : 204031

Patent Use Code : U-1499

Delist Requested :

Patent Use Description : MANAGEMENT OF ACUTE PA...

Patent Expiration Date : 2032-05-16

blank

06

arrow
Antibody Engineering
Not Confirmed
arrow
Antibody Engineering
Not Confirmed

ACETAMINOPHEN; OXYCODONE HYDROCHLORIDE

US Patent Number : 7976870

Drug Substance Claim :

Drug Product Claim :

Application Number : 204031

Patent Use Code : U-1498

Delist Requested :

Patent Use Description : METHOD OF TREATING PAT...

Patent Expiration Date : 2027-06-01

blank

07

arrow
Antibody Engineering
Not Confirmed
arrow
Antibody Engineering
Not Confirmed

ACETAMINOPHEN; OXYCODONE HYDROCHLORIDE

US Patent Number : 9468636

Drug Substance Claim :

Drug Product Claim :

Application Number : 204031

Patent Use Code : U-1499

Delist Requested :

Patent Use Description : MANAGEMENT OF ACUTE PA...

Patent Expiration Date : 2032-05-16

blank

08

arrow
Antibody Engineering
Not Confirmed
arrow
Antibody Engineering
Not Confirmed

ACETAMINOPHEN; OXYCODONE HYDROCHLORIDE

US Patent Number : 8372432

Drug Substance Claim :

Drug Product Claim : Y

Application Number : 204031

Patent Use Code : U-1499

Delist Requested :

Patent Use Description : MANAGEMENT OF ACUTE PA...

Patent Expiration Date : 2029-03-11

blank

09

arrow
Antibody Engineering
Not Confirmed
arrow
Antibody Engineering
Not Confirmed

ACETAMINOPHEN; OXYCODONE HYDROCHLORIDE

US Patent Number : 9050335

Drug Substance Claim :

Drug Product Claim : Y

Application Number : 204031

Patent Use Code :

Delist Requested :

Patent Use Description :

Patent Expiration Date : 2032-05-16

blank

10

arrow
Antibody Engineering
Not Confirmed
arrow
Antibody Engineering
Not Confirmed

ACETAMINOPHEN; OXYCODONE HYDROCHLORIDE

US Patent Number : 8597681

Drug Substance Claim :

Drug Product Claim : Y

Application Number : 204031

Patent Use Code :

Delist Requested :

Patent Use Description :

Patent Expiration Date : 2030-12-21

blank